These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Monitoring patients at risk for drug-induced opacities. Blaho K J Ophthalmic Nurs Technol; 2000; 19(6):302-3. PubMed ID: 11933522 [No Abstract] [Full Text] [Related]
4. Quetiapine: are we overreacting in our concern about cataracts (the beagle effect)? Stip E; Boisjoly H Can J Psychiatry; 1999 Jun; 44(5):503. PubMed ID: 10389614 [No Abstract] [Full Text] [Related]
5. In response to Furst et al, "Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin". Geller W; Smith M; Winter H; Brecher M Biol Psychiatry; 2002 Nov; 52(9):914; author reply 914-5. PubMed ID: 12399147 [No Abstract] [Full Text] [Related]
6. Hypothyroidism induced by quetiapine: a case report. Liappas J; Paparrigopoulos T; Mourikis I; Soldatos C J Clin Psychopharmacol; 2006 Apr; 26(2):208-9. PubMed ID: 16633154 [No Abstract] [Full Text] [Related]
7. Priapism associated with routine use of quetiapine: case report and review of the literature. Davol P; Rukstalis D Urology; 2005 Oct; 66(4):880. PubMed ID: 16230163 [TBL] [Abstract][Full Text] [Related]
9. Quetiapine: efficacy, tolerability and safety in schizophrenia. Miodownik C; Lerner V Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113 [TBL] [Abstract][Full Text] [Related]
10. Dose-dependent constipation with higher doses of quetiapine: a case series. Raedler TJ; Reimer J; Wiedemann K Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649 [TBL] [Abstract][Full Text] [Related]
15. Leukopenia and neutropenia induced by quetiapine. Cowan C; Oakley C Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):292-4. PubMed ID: 16930797 [TBL] [Abstract][Full Text] [Related]
16. Quetiapine (Seroquel) and QT-interval prolongation. Med Lett Drugs Ther; 2011 Oct; 53(1374):79-80. PubMed ID: 21959358 [No Abstract] [Full Text] [Related]
17. Quetiapine-induced peripheral edema. Roy K; Astreika V; Dunn JE; Sappati Biyyani RS Gen Hosp Psychiatry; 2009; 31(2):194-5. PubMed ID: 19269545 [TBL] [Abstract][Full Text] [Related]
18. Dose-related exacerbation of obsessive-compulsive symptoms with quetiapine treatment. Chen CH; Chiu CC; Huang MC Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):304-5. PubMed ID: 17826882 [No Abstract] [Full Text] [Related]
19. [Abuse of quetiapine. Two addicted patients with borderline personality disorder]. Galyuk TM; de Backer G; de Jong CA; Beers E; Loonen AJ Ned Tijdschr Geneeskd; 2009 Apr; 153(14):674-6. PubMed ID: 19425328 [No Abstract] [Full Text] [Related]
20. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Nasrallah HA; Brecher M; Paulsson B Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]